Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pyxis Oncology (PYXS) Non Operating Investment Income (2024 - 2025)

Pyxis Oncology (PYXS) has disclosed Non Operating Investment Income for 2 consecutive years, with $74000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Non Operating Investment Income fell 83.66% to $74000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$282000.0, a N/A change, with the full-year FY2024 number at $107000.0, up 69.84% from a year prior.
  • Non Operating Investment Income was $74000.0 for Q3 2025 at Pyxis Oncology, up from -$54000.0 in the prior quarter.
  • In the past five years, Non Operating Investment Income ranged from a high of $453000.0 in Q3 2024 to a low of -$181000.0 in Q4 2024.